Although they represent a small proportion of NSCLC cases, the absolute number of ALK-positive NSCLC patients is greater than that of ALK-positive ALCL due to the greater worldwide incidence of lung cancer [17]. This evidence concerns the gene ALK and non-small cell lung carcinoma.